Could adding cabergoline boost ovulation in PCOS?
NCT ID NCT07168837
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether adding cabergoline to the standard drug letrozole helps women with PCOS ovulate more often. One hundred women took either letrozole alone or letrozole plus cabergoline. Researchers tracked ovulation using ultrasound starting on day 10 of the menstrual cycle.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Letrozole and cabergoline tablets
- What this could lead to
- If the combination works better, it could offer a more effective option for inducing ovulation in women with PCOS who struggle to conceive.
- What could go wrong
- This is a small, completed trial with 100 participants, so results may not apply to all women with PCOS. Adding cabergoline may also increase side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PCOS (POLYCYSTIC OVARY SYNDROME) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Al-Azhar University Hospitals
Asyut, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gut microbiome transplant boost fertility in PCOS?
- A simple blood test may flag hidden insulin problems in PCOS
- Can tracking PCOS over time unlock better care?
- Could two common supplements tame PCOS hormone chaos?
- Sugar test reveals hidden metabolic clues in PCOS
- New PCOS study aims to map hidden patterns of the condition